Tools
Tools
Coveney, C.R.E. 
ORCID: 0000-0001-7047-6408,
2016.
Evaluation of proteomic and transcriptomic biomarker discovery technologies in ovarian cancer.
PhD, Nottingham Trent University.
|
Text
170523_TheesiiiiissAmendmentsGBPrrofDJBProofHandedIn.pdf - Published version Download (7MB) | Preview |
Abstract
Novel, specific and sensitive biomarkers are prerequisite to improve diagnosis and prognosis of patients with ovarian cancer. Firstly, a proteomic bottom-up MALDI-TOF mass spectrometric profiling analysis was conducted on a cohort of sixty serum samples specifically collected for this purpose. An in-house stepwise Artificial Neural Network (ANN) algorithm generated a biomarker panel of m/z peaks which differentiated cancer from aged matched controls with an accuracy of 91% and error of 9%, identities were inferred where possible and validation conducted using ELISA on the same cohort. Lack of complete verification, or the ability to verify the full panel lead to an in-depth evaluation of the strategy used with the aim to repeat with an improved methodology. Following this, a feasibility analysis and evaluation was performed on the next generation of equipment for sample fractionation prior to analysis on multiple replicates of stock human serum collected in the same way as the ovarian cohort. The results of which combined with the limited amount of available ovarian cancer sample cohort altered the trajectory of the project to the mining of transcriptomic data acquired from an online data repository. A meta-analysis approach was applied to two carefully selected gene expression microarray data sets ANNs, Cox Univariate Survival analyses and T-tests were used to filter genes whose expression were consistently significantly associated with patient survival times. A list of 56 genes were refined from a potential 37000 gene probes to be taken forward for verification for which more freely available online resources such as SRING, Kaplan Meier Plotter and KEGG were utilised. The list of 56 genes of interest were refined to seven using a larger cohort of transcriptomic data, of the seven one, EDNRA, was selected for translational verification using immunohistochemistry of a tissue microarray of ovarian cancer specimens. Significant association is seen with cancer stage, grade and histology. The merits and flaws of the verification are discussed and future work and direction for research is suggested.
| Item Type: | Thesis |
|---|---|
| Creators: | Coveney, C.R.E. |
| Date: | October 2016 |
| Rights: | This work is the intellectual property of the author. You may copy up to 5% of this work for private study, or personal, non-commercial research. Any re-use of the information contained within this document should be fully referenced, quoting the author, title, university, degree level and pagination. Queries or requests for any other use, or if a more substantial copy is required, should be directed to the owner(s) of the Intellectual Property Rights |
| Divisions: | Schools > School of Science and Technology |
| Record created by: | Linda Sullivan |
| Date Added: | 07 Jul 2017 10:49 |
| Last Modified: | 24 Jun 2021 15:11 |
| URI: | https://irep.ntu.ac.uk/id/eprint/31212 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
